@gladstoneinst.bsky.social
To drive a new era of discovery in disease-oriented science and to mentor tomorrow’s leaders in an inspiring and diverse environment.
@gladstoneinst.bsky.socialInduced pluripotent stem cell technology has already opened countless new possibilities for treating disease, but Shinya Yamanaka says he believes the best is yet to come.
@gladstoneinst.bsky.socialThe company has been working with Steve Finkbeiner's team at Gladstone since January to search for molecules targeting alpha-synuclein, a protein involved in Parkinson's disease.
@gladstoneinst.bsky.socialSteve Finkbeiner discusses the remarkable potential of AI to advance science—and the risk of too-stringent government regulations on AI hampering discovery.
@gladstoneinst.bsky.socialSeth Shipman (@seth-shipman.bsky.social) )has been recognized for pioneering molecular technologies that record cellular activity, expand genome editing, and target antibiotic-resistant superbugs.
@gladstoneinst.bsky.socialResearchers from Melanie Ott's lab identify the SARS-CoV-2 protein ORF8 as a driver of lung inflammation, revealing how infected macrophages may worsen severe COVID-19. @theottlab.bsky.social
@gladstoneinst.bsky.socialGladstone swept this year's UCSF Postdoc Slam 🏆 🥇 Yolanda Martí-Mateos (Jain Lab) shared how red blood cells at high altitude could unlock new diabetes treatments. 💙 Shoshana Williams (Ott Lab) received the People's Choice Award for a CRISPR test strip that could speed up TB diagnosis.
@gladstoneinst.bsky.social🚨 NEW PUBLICATION 🚨 "Detectrons convert transient RNA sequences into stable DNA barcodes for high-throughput analysis of RNA-dependent processes"
@seth-shipman.bsky.social
@jihoon-han.bsky.social
@natbiotech.nature.com
@gladstoneinst.bsky.socialGladstone's Jeanne Paz reflects on her early-career years in the lab of 2026 Nobel Prize winner Karl Deisseroth and explains how optogenetics has advanced epilepsy research.
@gladstoneinst.bsky.socialInspired by bacterial biology, the Gladstone-developed “Detectron” opens up new possibilities for disease research and potentially treatments.
New from the lab of @seth-shipman.bsky.social
@staciedodgson.bsky.socialReposted by @gladstoneinst.bsky.social📣📣 Looking for new faculty @gladstoneinst.bsky.social @ucsanfrancisco.bsky.social Genomic Immunology: aprecruit.ucsf.edu/JPF05958
We are broadly interested in immunotherapy - discovery, design, engineering, and translation, across the full spectrum of modalities and disease indications.
@benoitbruneau.bsky.socialReposted by @gladstoneinst.bsky.social@gladstoneinst.bsky.social gang ready for the @americanheart.bsky.social Heart Walk!
@natrevgenet.nature.comReposted by @gladstoneinst.bsky.socialMachine learning and statistical methods for molecular quantitative trait loci go.nature.com/4d9DTTi
New #Review by @barbaraengelhardt.bsky.social @gladstoneinst.bsky.social, Joshua S. Weinstock @emoryuniversity.bsky.social, Sarah K. Nyquist & @alexisbattle.bsky.social @jhu.edu out now!
@natbiotech.nature.comReposted by @gladstoneinst.bsky.socialDetectrons convert transient RNA sequences into stable DNA barcodes for high-throughput analysis of RNA-dependent processes - @seth-shipman.bsky.social @gladstoneinst.bsky.social www.nature.com/articles/s41...
@gladstoneinst.bsky.socialIt's Down Syndrome Awareness Month. Nearly 50% of babies with Down syndrome are born with heart defects. Our scientists used stem cells + gene editing + AI to find the gene behind it.
@gladstoneinst.bsky.socialGilbert Herrera, grad student at the Gladstone-UCSF Institute of Genomic Immunology, has been named the Ellen & Bernard Marson Fellow.
The award provides 3 years of support for a promising trainee pursuing innovative immunotherapy research.
Read more: https://bit.ly/4hGCrJy
@gladstoneinst.bsky.socialGladstone is among the early users of Anthropic’s Claude Science platform, which is being used to support new approaches to biological research.
@gladstoneinst.bsky.socialGladstone Associate Investigator Seth Shipman shares his thoughts on Anthropic's claim that its scientists used AI to discover new enzymes with promise for biotechnology.
@gladstoneinst.bsky.socialA team of scientists at Gladstone and UCSF discovered how a SARS-CoV-2 protein reprograms immune cells to accelerate viral spread, pointing to a new strategy for therapeutic intervention.
Read more: https://bit.ly/4hk8sad
@gladstoneinst.bsky.socialOur Gladstone community came out in force for the San Francisco Heart Walk! We had 91 walkers across 11 teams, and raised $1,766.40 for cardiovascular research. So much gratitude for everyone who walked, donated, and cheered us on. ❤️
@gladstoneinst.bsky.socialIt's World Heart Day. Heart failure affects approximately 64 million people worldwide. At Gladstone, Michael Alexanian is asking: what if we could just switch it off? He's found two genes, BRD4 & MEOX1, that may hold the answer.
